Vaccine development against theTaenia soliumparasite

Current Vaccine Development against Plague

Yersinia pestis, the causative organism of the plague, has played an important role in shaping human history. Plague is an illness that may manifest in bubonic, pneumonic, or septicemic form. Natural outbreaks devastated entire populations in medieval times and an estimated 200 million humans were killed by plague throughout history. The organism can still be found today throughout the world, i...

Parasitology Vaccine Development against Neospora

ABsTRAcr. Neospora c'aninum is a recognized protozoan parasite of a wjde range of marnmalian hosts, and was reported for the first time in 1988. The isolation f its oocysts in deg's faeces in 1998 led to its establishment as a parasitic species undergoing typical coccidian life cycle, Infection with N, caninum causes paralysis and death in young liyestock and companion animals, and is associate...

Vaccine Development Against Leishmania donovani

Visceral leishmaniasis (VL) caused by Leishmania donovani and Leishmania infantum/chagasi represents the second most challenging infectious disease worldwide, leading to nearly 500,000 new cases and 60,000 deaths annually. Zoonotic VL caused by L. infantum is a re-emergent canid zoonoses which represents a complex epidemiological cycle in the New world where domestic dogs serve as a reservoir h...

Vaccine development against Neisseria meningitidis

Meningococcal disease is communicable by close contact or droplet aerosols. Striking features are high case fatality rates and peak incidences of invasive disease in infants, toddlers and adolescents. Vaccine development is hampered by bacterial immune evasion strategies including molecular mimicry.As for Haemophilus influenzae and Streptococcus pneumoniae, no vaccine has therefore been develop...

Development of an Attenuated Live Virus Vaccine against Sheep Pox